Amin Al-Shami

1.6k total citations
19 papers, 1.3k citations indexed

About

Amin Al-Shami is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Amin Al-Shami has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Amin Al-Shami's work include Cell Adhesion Molecules Research (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Immune Cell Function and Interaction (4 papers). Amin Al-Shami is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Immune Cell Function and Interaction (4 papers). Amin Al-Shami collaborates with scholars based in United States, Canada and Malaysia. Amin Al-Shami's co-authors include Paul H. Naccache, Warren J. Leonard, Rosanne Spolski, John A. Kelly, Andrea Keane‐Myers, Pamela L. Schwartzberg, Terry J. Fry, Crystal L. Mackall, Akhilesh Pandey and Sylvain Bourgoin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Amin Al-Shami

17 papers receiving 1.2k citations

Peers

Amin Al-Shami

IMMUN

PHYSI

DERMA

Andreas Kerstan Germany

Jonathan J. Lyons United States

B. M. Czarnetzki Germany

Daocheng Zhu United States

Caroline Diveu France

Hua-Chen Chang United States

Elisabetta Agea Italy

María Ángeles García-López Spain

Jacoba Flier Netherlands

Sigrid Vollmer Germany

Andreas Kerstan Germany

Amin Al-Shami

550 ×0.9

IMMUN

406 ×1.0

107 ×0.3

PHYSI

254 ×0.7

398 ×1.2

DERMA

Citations per year, relative to Amin Al-Shami Amin Al-Shami (= 1×) peers Andreas Kerstan

Countries citing papers authored by Amin Al-Shami

Since Specialization

Citations

This map shows the geographic impact of Amin Al-Shami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amin Al-Shami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amin Al-Shami more than expected).

Fields of papers citing papers by Amin Al-Shami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amin Al-Shami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amin Al-Shami. The network helps show where Amin Al-Shami may publish in the future.

Co-authorship network of co-authors of Amin Al-Shami

This figure shows the co-authorship network connecting the top 25 collaborators of Amin Al-Shami. A scholar is included among the top collaborators of Amin Al-Shami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amin Al-Shami. Amin Al-Shami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Emran, Abdullah Al, Yutian Zhang, Yi Yang, et al.. (2025). Abstract 2115: SIM0680, a potent antibody-drug conjugate for the treatment of solid tumors expressing ENPP3. Cancer Research. 85(8_Supplement_1). 2115–2115.

Shi, Chunhua, Guojun Yang, Qing Shi, et al.. (2023). Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia. 37(10). 2006–2016. 6 indexed citations

Césaro, Annabelle, Joan Defrêne, Nathalie Pagé, et al.. (2019). Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice. PLoS ONE. 14(8). e0221528–e0221528. 10 indexed citations

Hu, Jiancheng, Shannon K. Oda, Erin Donovan, et al.. (2014). Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response. The Journal of Immunology. 193(1). 85–95. 39 indexed citations

Oda, Shannon K., Pamela Strauch, Yuko Fujiwara, et al.. (2013). Lysophosphatidic Acid Inhibits CD8 T-cell Activation and Control of Tumor Progression. Cancer Immunology Research. 1(4). 245–255. 72 indexed citations

Oravecz, Tamás, Wei-Chun Chang, Kanchan G. Jhaver, et al.. (2013). OP0195 Genetic and Pharmacologic Inhibition of MST1 Blocks Lymphocyte Function and Protects Against Inflammation and Autoimmunity. Annals of the Rheumatic Diseases. 72. A118–A118.

Al-Shami, Amin, et al.. (2013). Integrin-α FG-GAP Repeat-Containing Protein 2 Is Critical for Normal B Cell Differentiation and Controls Disease Development in a Lupus Model. The Journal of Immunology. 191(7). 3789–3798. 8 indexed citations

Al-Shami, Amin, Kanchan G. Jhaver, Peter Vogel, et al.. (2010). Regulators of the Proteasome Pathway, Uch37 and Rpn13, Play Distinct Roles in Mouse Development. PLoS ONE. 5(10). e13654–e13654. 76 indexed citations

Al-Shami, Amin, Dhaya Seshasayee, Flavius Martin, et al.. (2010). The Adaptor Protein Sh2d3c Is Critical for Marginal Zone B Cell Development and Function. The Journal of Immunology. 185(1). 327–334. 10 indexed citations

10.

Kovanen, Panu E., Jérôme Bernard, Amin Al-Shami, et al.. (2008). T-cell Development and Function Are Modulated by Dual Specificity Phosphatase DUSP5. Journal of Biological Chemistry. 283(25). 17362–17369. 49 indexed citations

11.

Lang, Mark L., Roy A. Fava, Martin Grundy, et al.. (2007). A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling. Blood. 111(1). 344–350. 9 indexed citations

12.

Kovanen, Panu E., Lynn Young, Amin Al-Shami, et al.. (2005). Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. International Immunology. 17(8). 1009–1021. 45 indexed citations

13.

Al-Shami, Amin, Rosanne Spolski, John A. Kelly, Andrea Keane‐Myers, & Warren J. Leonard. (2005). A role for TSLP in the development of inflammation in an asthma model. The Journal of Experimental Medicine. 202(6). 829–839. 419 indexed citations

14.

Al-Shami, Amin, Rosanne Spolski, John A. Kelly, et al.. (2004). A Role for Thymic Stromal Lymphopoietin in CD4+ T Cell Development. The Journal of Experimental Medicine. 200(2). 159–168. 194 indexed citations

15.

Al-Shami, Amin & Paul H. Naccache. (1999). Granulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils. Journal of Biological Chemistry. 274(9). 5333–5338. 80 indexed citations

16.

Al-Shami, Amin, et al.. (1998). Granulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils. Journal of Biological Chemistry. 273(2). 1058–1063. 151 indexed citations

17.

Al-Shami, Amin, Caroline Gilbert, Frédéric Barabé, Muriel Gaudry, & Paul H. Naccache. (1997). Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates. Journal of Immunological Methods. 202(2). 183–191. 31 indexed citations

18.

Al-Shami, Amin, Sylvain Bourgoin, & Paul H. Naccache. (1997). Granulocyte-Macrophage Colony-Stimulating Factor–Activated Signaling Pathways in Human Neutrophils. I. Tyrosine Phosphorylation-Dependent Stimulation of Phosphatidylinositol 3-Kinase and Inhibition by Phorbol Esters. Blood. 89(3). 1035–1044. 52 indexed citations

19.

Naccache, Paul H., Caroline Gilbert, Frédéric Barabé, et al.. (1997). Agonist-specific tyrosine phosphorylation of Cbl in human neutrophils. Journal of Leukocyte Biology. 62(6). 901–910. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact